Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 6961212
[patent_doc_number] => 20010012611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-09
[patent_title] => 'Method and system for anonymously testing for a human malady'
[patent_app_type] => new
[patent_app_number] => 09/740710
[patent_app_country] => US
[patent_app_date] => 2000-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8443
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20010012611.pdf
[firstpage_image] =>[orig_patent_app_number] => 09740710
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/740710 | Method and system for anonymously testing for a human malady | Dec 18, 2000 | Abandoned |
09/719665 | Azaftig, a proteoglycan for monitoring cachexia and for control of obesity | Dec 13, 2000 | Abandoned |
09/647395 | Retrovirus envelope glycoprotein mutants and biological applications | Dec 3, 2000 | Abandoned |
Array
(
[id] => 1091916
[patent_doc_number] => 06824793
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-30
[patent_title] => 'Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants'
[patent_app_type] => B1
[patent_app_number] => 09/724661
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10123
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/824/06824793.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724661
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724661 | Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants | Nov 27, 2000 | Issued |
Array
(
[id] => 7612950
[patent_doc_number] => 06902884
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-06-07
[patent_title] => 'Method and tool for prognosticating HIV infection in a subject by measuring soluble urokinase plasminogen activator receptor, degradation products thereof, and urokinase plasminogen activator receptor'
[patent_app_type] => utility
[patent_app_number] => 10/148492
[patent_app_country] => US
[patent_app_date] => 2000-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 14772
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/902/06902884.pdf
[firstpage_image] =>[orig_patent_app_number] => 10148492
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/148492 | Method and tool for prognosticating HIV infection in a subject by measuring soluble urokinase plasminogen activator receptor, degradation products thereof, and urokinase plasminogen activator receptor | Nov 26, 2000 | Issued |
09/673025 | PEPTIDE LIGAND HAVING SPECIFIC AFFINITY FOR THE HIV 1 RETROVIRUS P24 PROTEIN | Nov 26, 2000 | Abandoned |
Array
(
[id] => 1452511
[patent_doc_number] => 06461608
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-08
[patent_title] => 'Bacteriophage composition useful in treating food products to prevent bacterial contamination'
[patent_app_type] => B1
[patent_app_number] => 09/718093
[patent_app_country] => US
[patent_app_date] => 2000-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6605
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/461/06461608.pdf
[firstpage_image] =>[orig_patent_app_number] => 09718093
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/718093 | Bacteriophage composition useful in treating food products to prevent bacterial contamination | Nov 21, 2000 | Issued |
Array
(
[id] => 1542068
[patent_doc_number] => 06372442
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-16
[patent_title] => 'Method of characterizing the degradation of type II collagen'
[patent_app_type] => B1
[patent_app_number] => 09/714146
[patent_app_country] => US
[patent_app_date] => 2000-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6928
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/372/06372442.pdf
[firstpage_image] =>[orig_patent_app_number] => 09714146
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/714146 | Method of characterizing the degradation of type II collagen | Nov 16, 2000 | Issued |
Array
(
[id] => 1309952
[patent_doc_number] => 06610305
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-26
[patent_title] => 'Safe attenuated bovine viral diarrhea viruses for use in pregnant cows'
[patent_app_type] => B1
[patent_app_number] => 09/706649
[patent_app_country] => US
[patent_app_date] => 2000-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6367
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610305.pdf
[firstpage_image] =>[orig_patent_app_number] => 09706649
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/706649 | Safe attenuated bovine viral diarrhea viruses for use in pregnant cows | Nov 5, 2000 | Issued |
Array
(
[id] => 1217238
[patent_doc_number] => 06706859
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-16
[patent_title] => 'HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV'
[patent_app_type] => B1
[patent_app_number] => 09/674674
[patent_app_country] => US
[patent_app_date] => 2000-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12026
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/706/06706859.pdf
[firstpage_image] =>[orig_patent_app_number] => 09674674
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/674674 | HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV | Nov 2, 2000 | Issued |
Array
(
[id] => 1484915
[patent_doc_number] => 06365395
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-02
[patent_title] => 'Process for removing protein aggregates and virus from a protein solution'
[patent_app_type] => B1
[patent_app_number] => 09/706003
[patent_app_country] => US
[patent_app_date] => 2000-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2001
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/365/06365395.pdf
[firstpage_image] =>[orig_patent_app_number] => 09706003
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/706003 | Process for removing protein aggregates and virus from a protein solution | Nov 2, 2000 | Issued |
09/698311 | Engineered chimera of protein fragments and methods of use thereof | Oct 26, 2000 | Abandoned |
09/646205 | Vaccine against sexually transmitted diseases | Oct 26, 2000 | Abandoned |
09/685164 | Release liner having a microreplicated topography | Oct 9, 2000 | Abandoned |
Array
(
[id] => 1109936
[patent_doc_number] => 06805882
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-19
[patent_title] => 'Therapeutic fractions of sources of HCG'
[patent_app_type] => B1
[patent_app_number] => 09/677152
[patent_app_country] => US
[patent_app_date] => 2000-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 93
[patent_no_of_words] => 61316
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/805/06805882.pdf
[firstpage_image] =>[orig_patent_app_number] => 09677152
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/677152 | Therapeutic fractions of sources of HCG | Oct 1, 2000 | Issued |
Array
(
[id] => 1333102
[patent_doc_number] => 06596688
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-22
[patent_title] => 'Method for promoting hematopoiesis'
[patent_app_type] => B1
[patent_app_number] => 09/675776
[patent_app_country] => US
[patent_app_date] => 2000-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 95
[patent_no_of_words] => 61290
[patent_no_of_claims] => 120
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596688.pdf
[firstpage_image] =>[orig_patent_app_number] => 09675776
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/675776 | Method for promoting hematopoiesis | Sep 28, 2000 | Issued |
Array
(
[id] => 1223949
[patent_doc_number] => 06699834
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-02
[patent_title] => 'Method for treating cancer'
[patent_app_type] => B1
[patent_app_number] => 09/675362
[patent_app_country] => US
[patent_app_date] => 2000-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 93
[patent_no_of_words] => 61329
[patent_no_of_claims] => 114
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/699/06699834.pdf
[firstpage_image] =>[orig_patent_app_number] => 09675362
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/675362 | Method for treating cancer | Sep 28, 2000 | Issued |
Array
(
[id] => 1301195
[patent_doc_number] => 06620416
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-16
[patent_title] => 'Method for treating HIV'
[patent_app_type] => B1
[patent_app_number] => 09/676739
[patent_app_country] => US
[patent_app_date] => 2000-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 94
[patent_no_of_words] => 61308
[patent_no_of_claims] => 103
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/620/06620416.pdf
[firstpage_image] =>[orig_patent_app_number] => 09676739
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/676739 | Method for treating HIV | Sep 28, 2000 | Issued |
Array
(
[id] => 1265586
[patent_doc_number] => 06660842
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-09
[patent_title] => 'Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen'
[patent_app_type] => B1
[patent_app_number] => 09/664945
[patent_app_country] => US
[patent_app_date] => 2000-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18567
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/660/06660842.pdf
[firstpage_image] =>[orig_patent_app_number] => 09664945
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/664945 | Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen | Sep 18, 2000 | Issued |
09/664025 | Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen | Sep 18, 2000 | Abandoned |